PLURISTEM THERAPEUTICS INC (31)

Browse by Contract Category

Contracts

Letter agreement by and between Pluristem Ltd. and Chen Franco-Yehuda, dated September 13, 2021 (Filed With SEC on September 13, 2021)
Form of Restricted Stock Unit Agreement (employees) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)
Form of Director and Officer Indemnification Agreement (Filed With SEC on February 8, 2021)
Amended and Restated Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated September 10, 2020 (Filed With SEC on September 10, 2020)
Letter agreement by and between Pluristem Ltd. and Yaky Yanay, dated September 13, 2021 (Filed With SEC on September 13, 2021)
Letter agreement by and between Pluristem Ltd. and Rose High Tech Ltd., dated September 13, 2021 (Filed With SEC on September 13, 2021)
Form of Restricted Stock Unit Agreement (directors) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)
Form of Restricted Stock Unit Agreement (executive officers) under the 2019 Equity Compensation Plan (Filed With SEC on September 13, 2021)
Placement Agency Agreement, dated February 2, 2021, between Pluristem Therapeutics Inc. and A.G.P./Alliance Global Partners (Filed With SEC on February 3, 2021)
Form of Securities Purchase Agreement, dated February 2, 2021, among Pluristem Therapeutics Inc. and the Purchasers named therein (Filed With SEC on February 3, 2021)
Guarantee Agreement by and among the European Investment Bank, Pluristem Ltd. and Pluristem GmbH dated, September 30, 2020 (Filed With SEC on November 5, 2020)
Guarantee Agreement by and among the European Investment Bank, Pluristem Therapeutics, Inc. and Pluristem GmbH, dated September 30, 2020 (Filed With SEC on November 5, 2020)
Finance Contract between the European Investment Bank, as Lender, and Pluristem GmBH, as borrower, and Pluristem Therapeutics Inc. and Pluristem Ltd., as Original Guarantors,... (Filed With SEC on September 10, 2020)
Amended and Restated Employment Agreement between Pluristem Ltd. and Chen Franco-Yehuda dated September 10, 2020 (Filed With SEC on September 10, 2020)
Amended and Restated Employment Agreement between Pluristem Ltd. and Yaky Yanay dated September 10, 2020 (Filed With SEC on September 10, 2020)
Summary of Directors Ongoing Compensation (Filed With SEC on September 10, 2020)
Description of Securities (Filed With SEC on September 10, 2020)
Form of Securities Purchase Agreement (Filed With SEC on May 5, 2020)
Form of Restricted Stock Agreement (Israeli directors and officers) under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)
orm of Restricted Stock Agreement under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)
Form of Stock Option Agreement under the 2019 Equity Compensation Plan (Filed With SEC on September 12, 2019)
Summary of Directors Ongoing Compensation (Filed With SEC on September 12, 2019)
Description of Securities (Filed With SEC on September 12, 2019)
Warrant Agreement by and between Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (including the form of Warrant certificate) (Filed With SEC on May 6, 2019)
Employment Agreement between Pluristem Ltd. and Chen Franco-Yehuda dated May 6, 2019 (Filed With SEC on May 6, 2019)
Subscription Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and ARK Genomic Revolution ETF (Filed With SEC on May 6, 2019)
Underwriting Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (Filed With SEC on May 6, 2019)
Form of Subscription Agreement (Filed With SEC on April 5, 2019)
Form of Warrant Agreement by and between Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (including the form of Warrant certificate) (Filed With SEC on April 5, 2019)
Underwriting Agreement, dated April 4, 2019, between Pluristem Therapeutics Inc. and Ladenburg Thalmann & Co. Inc., as representative of the underwriters named therein (Filed With SEC on April 5, 2019)
Open Market Sale AgreementSM, dated February 6, 2019, by and between the Company and Jefferies LLC (Filed With SEC on February 6, 2019)